SCHEMBL7746616

SCHEMBL7746616

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.65
FLT1 P17948 1/20 0.65
FLT4 P35916 1/20 0.65
KDM4E B2RXH2 3/20 0.42
APOBEC3A P31941 1/20 0.42
GFER P55789 1/20 0.42
HDAC1 Q13547 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTPN1 P18031 4/20 0.41
BACE1 P56817 1/20 0.41
DHODH Q02127 1/20 0.41
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CHUK O15111 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744663 0.92 KDR (0.76) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7744086 0.90 KDR (0.51) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7744049 0.87 KDR (0.52) KDRFLT1FLT4LMNA
SCHEMBL7739087 0.86 KDR (0.69) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7746627 0.86 KDR (0.48) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7746620 0.84 KDR (0.57) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7739078 0.82 KDR (0.68) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7739014 0.82 KDR (0.63) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7746598 0.82 KDR (0.58) KDRFLT1FLT4HDAC1
SCHEMBL7744052 0.81 KDR (0.52) KDRFLT1FLT4ADORA3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed